Advertisement
Screener

CORE LABORATORIES N.V. Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)

CORE LABORATORIES N.V. Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)

CORE LABORATORIES N.V. reported Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss) of -$18.36 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-10.

Discontinued › Income Statement › Other Income

us-gaap:DefinedBenefitPlanActuarialGainLoss · last filed 2023-02-10

  • CORE LABORATORIES N.V. defined benefit plan, benefit obligation, actuarial gain (loss) for fiscal 2022 was -$18.36M.
  • CORE LABORATORIES N.V. defined benefit plan, benefit obligation, actuarial gain (loss) for fiscal 2021 was -$5.28M, a 204.45% decline from fiscal 2020.
  • CORE LABORATORIES N.V. defined benefit plan, benefit obligation, actuarial gain (loss) for fiscal 2020 was $5.06M, a 36.63% decline from fiscal 2019.
  • CORE LABORATORIES N.V. defined benefit plan, benefit obligation, actuarial gain (loss) for fiscal 2019 was $7.98M.
Period endDefined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss) 12 monthDefined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss) 12 month as first filed
2022-12-31-$18.36M
10-K · filed 2023-02-10
2021-12-31-$5.28M
10-K · filed 2023-02-10
2020-12-31$5.06M
10-K · filed 2022-02-10
2019-12-31$7.98M
10-K · filed 2021-02-08
2018-12-31-$383.00K
10-K · filed 2020-02-10
$383.00K
10-K · filed 2019-02-11
2017-12-31$1.00M
10-K · filed 2019-02-11
-$1.00M
10-K · filed 2018-02-12
2016-12-31$5.22M
10-K · filed 2018-02-12
2015-12-31-$4.42M
10-K · filed 2017-02-10
2014-12-31$16.67M
10-K · filed 2016-02-12
2013-12-31-$843.00K
10-K · filed 2015-02-17
2012-12-31$10.01M
10-K · filed 2014-02-13
2011-12-31$2.02M
10-K · filed 2013-02-19